Filing Details
- Accession Number:
- 0000899243-22-001527
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-10 20:37:57
- Reporting Period:
- 2022-01-06
- Accepted Time:
- 2022-01-10 20:37:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1658551 | Amylyx Pharmaceuticals Inc. | AMLX | Pharmaceutical Preparations (2834) | 464600503 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1727550 | R. Paul Fonteyne | C/O Amylyx Pharmaceuticals, Inc. 43 Thorndike Street Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-01-06 | 3,947 | $19.00 | 3,947 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2022-01-06 | 8,400 | $0.00 | 8,400 | $19.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,400 | 2032-01-06 | No | 4 | A | Direct |
Footnotes
- This option shall vest in full on the date of the Corporation's 2022 Annual Stockholders Meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Billionaire Hedge Funds
